
Famotack50 ml
Square Pharmaceuticals PLC.
Famotidine is a histamine H2-receptor antagonist used to reduce gastric acid secretion.
Famotidine is a histamine H2-receptor antagonist used to reduce gastric acid secretion. Its established, evidence-based uses include:
Famotidine does not cure the underlying acid-related disorder; it controls symptoms and promotes healing while the underlying condition is managed.
The dose and duration of Famotidine therapy depend on the indication being treated. It can be taken with or without food. Doses should be adjusted in patients with renal impairment (see below).
| Indication | Usual adult dose | Typical duration |
|---|---|---|
| Active duodenal ulcer | 40 mg once daily at bedtime, or 20 mg twice daily | Up to 8 weeks |
| Maintenance therapy (duodenal ulcer) | 20 mg once daily at bedtime | As directed by physician |
| Active benign gastric ulcer | 40 mg once daily at bedtime | Up to 8 weeks |
| Symptomatic non-erosive GERD | 20 mg twice daily | Up to 6 weeks |
| Erosive esophagitis (GERD) | 20-40 mg twice daily | Up to 12 weeks |
| Pathological hypersecretory conditions (e.g. Zollinger-Ellison syndrome) | Starting 20 mg every 6 hours; adjusted individually (may require higher doses) | As clinically indicated |
| Heartburn / acid indigestion (OTC-strength use) | 10 mg, taken 15-60 minutes before symptoms expected or at onset of symptoms; do not exceed 2 doses in 24 hours | Short-term, symptomatic |
Dosage reduction or extended dosing intervals are required when creatinine clearance is below 60 mL/min, since Famotidine is primarily renally excreted. In patients with severe renal impairment, doses are typically reduced by half or the interval extended (e.g., every other day dosing), under physician supervision.
No specific dosage adjustment is generally required for hepatic impairment alone, as Famotidine undergoes minimal hepatic metabolism, but caution is advised.
Famotidine is generally well tolerated. Most side effects are mild and transient.
Patients should seek prompt medical attention for signs of a severe allergic reaction (swelling of the face/throat, difficulty breathing, severe rash) or unusual symptoms such as severe confusion.
Famotidine is contraindicated in patients with a known history of hypersensitivity (including serious hypersensitivity reactions such as anaphylaxis) to Famotidine or to any other H2-receptor antagonist, since cross-sensitivity within this drug class has been reported.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.